Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ: XERS · Real-Time Price · USD
8.20
+0.04 (0.49%)
Sep 18, 2026, 4:00 PM EDT - Market closed
Xeris Biopharma Holdings Market Cap
Xeris Biopharma Holdings has a market cap or net worth of $1.5 billion as of September 18, 2026. Its market cap has increased by 20.71% in one year.
Market Cap
1.50B
Enterprise Value
1.66B
1-Year Change
20.71%
Ranking
Category
Stock Price
$8.20
ChartMarket Cap Chart
Since October 6, 2021, Xeris Biopharma Holdings's market cap has increased from $295.78M to $1.50B, an increase of 405.46%. That is a compound annual growth rate of 38.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 1.50B | 14.78% |
| Dec 31, 2025 | 1.30B | 157.72% |
| Dec 31, 2024 | 505.39M | 55.70% |
| Dec 29, 2023 | 324.59M | 79.47% |
| Dec 30, 2022 | 180.86M | -50.50% |
| Dec 31, 2021 | 365.40M | 23.54% |
| Oct 6, 2021 | 295.78M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BioCryst Pharmaceuticals | 2.22B |
| Trulieve Cannabis | 2.13B |
| Prestige Consumer Healthcare | 2.13B |
| Bausch Health Companies | 2.12B |
| Alvotech | 2.10B |
| Perrigo Company | 1.88B |
| ANI Pharmaceuticals | 1.63B |
| Eton Pharmaceuticals | 1.59B |